INNOMEM was explicitly an Open Innovation Test Bed for nano-enabled membranes, with EMI Twente BV providing third-party infrastructure to the consortium.
EMI TWENTE BV
Dutch membrane pilot-line and manufacturing infrastructure company expanding into catalytic CO2 valorization and bio-based chemicals.
Their core work
EMI Twente BV is a private company based in Enschede, Netherlands — the city most closely associated with Europe's foremost membrane science research cluster at the University of Twente — that provides specialized manufacturing infrastructure and process services to EU research consortia. In both H2020 projects, the company contributed exclusively as a third party, most likely supplying access to pilot-scale membrane fabrication lines and advanced materials characterization capabilities that research teams need to move from laboratory proof-of-concept to validated scale. In INNOMEM they supported an Open Innovation Test Bed for nano-enabled membranes; in CATCO2NVERS their capabilities were deployed within an integrated catalytic system for converting bio-industrial CO2 emissions into value-added chemicals. They function as an industrial bridge between academic membrane research and practical scale-up, with an emerging footprint in sustainable catalytic chemistry.
What they specialise in
INNOMEM keywords list 'Manufacturing Pilot Lines' as a core capability area contributed by the company.
Advanced Characterization and Modelling is explicitly named alongside manufacturing pilot lines as an EMI Twente BV contribution in INNOMEM.
CATCO2NVERS engages electrocatalysis, enzymatic catalysis, and thermocatalysis for converting bio-industrial CO2 into glyoxylic acid, lactic acid, and related molecules.
CATCO2NVERS targets biopolymers, furan dicarboxylic methyl ester, and cyclic carbonate fatty acid methyl esters — all derived from CO2 and bio-industrial feedstocks.
How they've shifted over time
In their first H2020 project (INNOMEM, 2020), EMI Twente BV's contribution centred entirely on membrane fabrication infrastructure: pilot-scale manufacturing lines, advanced characterization, and materials modelling. Their second project (CATCO2NVERS, 2021) marks a clear pivot toward integrated catalytic chemistry — electrocatalysis, enzymatic catalysis, thermocatalysis — and the conversion of CO2 into a diverse palette of molecules including organic acids, esters, and biopolymers. This progression either reflects a deliberate expansion of their service portfolio beyond membranes into broader catalytic process support, or — more likely given the Enschede context — indicates that their membrane separation expertise is now being embedded within larger chemical process chains where membranes and catalysis work in tandem.
EMI Twente BV is moving from pure membrane technology toward integrated sustainable chemistry, where membrane separation and catalytic conversion combine in CO2 valorization and bio-based chemical production — a space with strong EU policy tailwinds and growing industrial demand.
How they like to work
EMI Twente BV has participated exclusively as a third party across all known H2020 projects, meaning consortia engage them for a defined service or facility access rather than as a research driver or decision-maker. This is not a company that leads projects or shapes research agendas; they are sought out for what they uniquely enable — most likely pilot-scale infrastructure or testing capabilities not easily replicated elsewhere. Despite this supporting role, they are embedded in notably large and well-funded consortia: 51 distinct partners across 14 countries through just two projects signals that they are pulled into broad, multi-partner European programmes rather than narrow bilateral arrangements.
Through two projects, EMI Twente BV has been connected to 51 unique partners across 14 countries, reflecting participation in large pan-European consortia well beyond the Dutch research space. Their Enschede location places them within a dense regional cluster of membrane technology companies and university spin-offs, which likely amplifies their visibility to international consortium builders.
What sets them apart
EMI Twente BV operates from Enschede, the city synonymous with one of Europe's premier membrane science programmes, giving them proximity to — and likely formal ties with — a world-class research ecosystem that consistently attracts large EU funding. As a private company rather than a research institute, they provide the industrial-scale infrastructure (pilot lines, characterization, process validation) that academic partners in EU consortia typically lack access to. Their recent expansion into CO2 catalysis within integrated process chains positions them at the intersection of membrane separation and green chemistry, a niche with strong strategic relevance to EU decarbonization goals.
Highlights from their portfolio
- INNOMEMDesignated as an EU Open Innovation Test Bed — a specific instrument for providing shared pilot infrastructure open to external users — making EMI Twente BV's manufacturing and characterization capabilities accessible to the broader European membrane R&D community.
- CATCO2NVERSAn ambitious multi-catalysis programme converting bio-industrial CO2 into a spectrum of value-added molecules, representing EMI Twente BV's most chemically diverse engagement and their first documented footprint in sustainable catalytic chemistry.